ASX Announcements
Change of Director's Interest Notice
Change of Director’s Interest Notice
Notification of cessation of securities - NAN
Appendix 3H (Notification of cessation of securities)
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Application for quotation of securities - NAN
Appendix 2A (Application for Quotation of Securities)
April
Billion-dollar medical start-ups say Trump could force a US move
Nanosonics chief executive Michael Kavanagh says the government should step in and help domestic development, a sentiment echoed by ResMed boss Mick Farrell.
Eli Lilly issues warning for Australia as Trump signals pharma tariffs
In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.
February 2023
Nanosonics readies for new product launch in late 2023
The disinfection device maker is reaping the rewards from a shake-up to its sales model, achieving better pricing across its device and consumable sales.
January 2023
ASX firms 0.6pc to nine-month high on reduced rate rise expectations
Australian 1-year bond yields sank below the cash rate after soft US retail sales preceded a weak December jobs report, prompting a shift in rate-rise expectations.
November 2022
ASX edges up 0.2pc but ends the week slightly lower
Mining companies and banks pushed the sharemarket 0.2 per cent higher on Friday, but the benchmark ended the week slightly lower.
October 2022
Why clean air is the Nanosonics founder’s next frontier
Maurie Stang is back in the disinfection game, this time forming a joint venture with VBreathe.
August 2022
Nanosonics enters new chapter after strategic shifts
Nanosonics’ net profit slid 57 per cent to $3.7 million, while revenue leapt 17 per cent to $120.3 million, as more hospitals adopted its disinfection device.
February 2022
All the profit results for February 22, 2022
Results briefing | News and analysis on today’s profit results from Alumina, AMA Group, ARB, AUB, Cochlear, Coles, Costa, Deterra, Estia, G8 Education, HomeCo Daily Needs, Hub24, Humm, Ingenia, Johns Lyng, Jumbo Interactive, Judo Bank, Macquarie Telecom, Macmahon, Monadelphous, Nanosonics, Perenti, RAM Essential, Regis Resources, Seven Group, Superloop, Uniti, Virtus, Whispr. Find updated reports and analysis here.
Nanosonics stock plunges 12pc on half-year profit slump
Shares in Nanosonics plunged in morning trade as the medical device business reported a sharp drop in profits.
September 2021
Buy, hold, sell: Nanosonics, WiseTech, Redbubble, Kogan, Monadelphous
Two fund managers discuss the stocks that returned disappointing results this earnings season.
August 2021
Nanosonics eyes 20pc growth after beating estimates
Shares in the infection prevention company surged 22 per cent after the company predicted a return to double-digit sales growth this financial year.
EMVision launches portable scanner to diagnose brain trauma
The ASX-listed med tech company aims to fast track stroke survival with its portable imaging technology.
February 2021
Nanosonics slides 8pc despite sales bounceback
The medical technology company’s boss says the first-half result was strong, as unit sales and procedural volumes started to recover from a pandemic slowdown.
January 2021
Healthcare outlook rests on vaccine rollout
Many healthcare companies were seriously disrupted while dealing with the fallout from COVID-19. As vaccines get rolled out, momentum is likely to return.
November 2020
Who are the market winners and losers in this new world order?
The US election and vaccine breakthrough have excited the markets, but stock pickers need to look beyond the news cycle to the structural shifts of the post-pandemic world.
August 2020
Nanosonics delays product launch due to pandemic
In the fourth quarter Nanosonics sales dried up as its representatives were unable to enter hospitals thanks to the COVID-19 pandemic.
June 2020
Buy, hold, sell: Nanosonics, Service Stream, InvoCare
Small caps come with robust balance sheets – but they also come at a price. Livewire Markets discusses which ones are worth paying for.
Buy, hold, sell: Nanosonics, Service Stream, InvoCare
Small caps come with robust balance sheets – but they also come at a price. Livewire Markets discusses which ones are worth paying for.
April 2020
Coronavirus restrictions make Nanosonics nervous for Q4
Nanosonics is uncertain how the COVID-19 outbreak could impact its fourth-quarter sales as access to hospitals becomes more limited.
March 2020
BHS: EML Payments; Nanosonics; Breville; City Chic Collective; WISR
Growth doesn't exist anymore, but we're going to talk about it regardless so up first one of the old market darlings being slaughtered. EML Payments, buy, hold or sell?